Assessment of COVID-19 deaths from cardiological perspective

Timor Omar1, Muammer Karakayalı1, Gökhan Perincek2

  • 1Department of Cardiology, M.D. Kars Harakani State Hospital, Kars, Turkey.

Acta Cardiologica
|April 7, 2021
PubMed

Insights

COVID-19 cardiac injury, indicated by elevated high-sensitivity troponin T (hs-TnT) and ECG abnormalities, significantly increases in-hospital mortality risk. Early identification and aggressive treatment are crucial for high-risk patients.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Internal Medicine

Background:

  • COVID-19 is associated with diverse cardiac complications and electrocardiographic (ECG) abnormalities.
  • Assessing cardiological parameters is vital for understanding COVID-19 patient outcomes.

Purpose of the Study:

  • To analyze cardiological parameters, including ECG and high-sensitivity troponin T (hs-TnT), in hospitalized COVID-19 patients.
  • To determine the association between these parameters and in-hospital mortality.

Main Methods:

  • Retrospective analysis of 453 hospitalized COVID-19 patients with known outcomes.
  • Comparison of demographic, comorbidity, laboratory, and ECG findings between survivors and non-survivors, and between cardiac injury and no-cardiac injury subgroups.

Main Results:

  • Cardiac injury was linked to significantly higher in-hospital mortality.
  • Patients with cardiac injury showed increased frequencies of atrial fibrillation, axis change, ST-segment/T-wave changes, fragmented QRS, and premature contractions.
  • Non-survivors exhibited longer QRS intervals, more frequent ST-segment/T-wave changes, and an isolated S1Q3T3 pattern. Elevated hs-TnT levels at admission were markedly higher in non-survivors.
  • hs-TnT, age, and respiratory rate were independent predictors of mortality. Comorbidities were more prevalent in non-survivors and the cardiac injury group.

Conclusions:

  • Elevated hs-TnT and ECG abnormalities indicating cardiac involvement on admission predict poor prognosis and increased in-hospital mortality in COVID-19 patients.
  • Prioritized and aggressive therapeutic strategies are recommended for these high-risk patients to reduce mortality.
Abstract

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
122
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
125
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
96
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
185
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
121
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
74